an appropriate Women Falling Short on Birth Defect Prevention vacationers

an appropriate Women Falling Short on Birth Defect Prevention vacationers

nail clipping Women Falling Short on Birth Defect Prevention push back
 
Photo :Women Falling Short on Birth Defect Prevention

is very (*this news item will not be available after 01/11/2018) Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Only a third of women are taking a multivitamin containing folic acid -- a nutrient known to prevent serious birth defects -- before they know they're pregnant, a new survey has found. The poll, conducted by the March of Dimes, also revealed significant racial disparities: Just 10 percent of black women and 27 percent of Hispanic women of childbearing age report taking multivitamins with folic acid before pregnancy. "One of the things that's striking for us is how much more we need to make sure women understand the importance of being healthy before pregnancy," said Stacey Stewart, president of the March of Dimes Foundation. "Half of all pregnancies are unexpected, which means women of childbearing age need to be doing all they can to be healthy in the event they do get pregnant," she said. In the United States, more than 120,000 babies -- about 3 percent of all births -- will be born with birth defects this year, including about 3,000 babies born with neural tube defects, according to March of Dimes estimates. Up to 70 percent of the neural tube defects, which affect the brain and spine, could be prevented if all women of childbearing age took daily multivitamins containing folic acid, the group said. The survey on prenatal health measures, conducted online in August 2017 by The Harris Poll on behalf of the March of Dimes, polled a nationally representative sample of more than 1,000 U.S. women, 18 to 45 years of age. It also found that: 77 percent of women are concerned there may be changes to the U.S. health care system that may hamper access to prenatal care, 43 percent of women say that cost affects when and whether they seek prenatal care, nearly two-thirds of women identify folic acid as an important nutrient in birth defect prevention, and only 40 percent identify iron, calcium and vitamin D as other vitamins important for this purpose, 97 percent of women report taking prenatal vitamins or multivitamins during a pregnancy, 13 percent of women do not know that avoiding smoking or tobacco products reduces the risk for birth defects, and 12 percent are unaware that eliminating drinking and illegal drugs would do the same. Stewart said that the number of women concerned about possible changes to the U.S. health care system, as well as costs, points to a serious regard for their access to proper care for themselves and their pregnancies. "At the March of Dimes, we work very hard to make sure that members of Congress, especially over the last several months, understand how important it is to take into account the health of women and mothers, and the impact health care changes would have on pregnancies and newborn babies," she said. "We have to make sure the most vulnerable in our country are safe and protected, and that certainly has to be true for babies," Stewart added. Dr. Michael Pirics, an obstetrician-gynecologist at Houston Methodist Hospital in Texas, said he wasn't surprised by the new survey findings, noting that many women don't seek preconception care "either because they don't know that kind of thing is important or they're not getting regular gynecological checkups where it's addressed." He was not involved with the survey. Pirics called the revelation of racial and ethnic disparities in multivitamin use among women of childbearing age "one snapshot of a larger problem" that he also found not surprising. All women in this age group should discuss taking folic acid-containing vitamins with their doctors well before conception, he said. "But the idea of prevention is an overarching concern that should be more valued in our society," Pirics added. "We should be encouraging women to continue getting regular health visits, both for their own health and the health of their potential pregnancies in the future." SOURCES: Stacey Stewart, president, March of Dimes Foundation, White Plains, N.Y.; Michael Pirics, M.D., obstetrician-gynecologist, Houston Methodist Hospital, Texas; "Prenatal Health & Nutrition" survey, March of Dimes, August 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Health Disparities Recent Health News ward off


exquisite Women Falling Short on Birth Defect Prevention for bathroom
prospective customers Silverseal Hydrogel Dressing detect

prospective customers Silverseal Hydrogel Dressing detect

grow to be Silverseal Hydrogel Dressing ward off
 
Photo :Silverseal Hydrogel Dressing

hastens Silverseal Hydrogel Dressing Generic Name: Silver Pads (SIL ver) Brand Name: Acticoat Moisture Control, Acticoat Surgical, AgIE-GRX, Algicell Ag, Allevyn Ag Gentle, ...show all 9 brand names. Aquacel Ag Foam, Durafiber, Durafiber Ag, Silverseal Hydrogel Dressing Overview Side Effects Interactions Reviews Q & A More Uses of Silverseal Hydrogel Dressing: It is used to treat minor cuts, scrapes, or burns. It is used to treat skin irritation. It is used to promote healing of skin ulcers and wounds. Slideshow Shingles: Settling The Score What do I need to tell my doctor BEFORE I take Silverseal Hydrogel Dressing? If you have an allergy to Silverseal Hydrogel Dressing (silver pads) or any part of this medicine. If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you have a defibrillator or pacemaker. If you are getting radiation. This medicine may interact with other drugs or health problems. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take Silverseal Hydrogel Dressing with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. What are some things I need to know or do while I take Silverseal Hydrogel Dressing? Tell all of your health care providers that you take this medicine. This includes your doctors, nurses, pharmacists, and dentists. Do not use longer than you have been told by the doctor. Talk with your doctor before you use other drugs or products on your skin. If you are having an MRI, talk with doctor. It will need to be removed. Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using Silverseal Hydrogel Dressing while you are pregnant. Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby. How is this medicine (Silverseal Hydrogel Dressing) best taken? Use this medicine as ordered by your doctor. Read all information given to you. Follow all instructions closely. Do not take Silverseal Hydrogel Dressing by mouth. Use on your skin only. Keep out of your mouth, nose, ears, and eyes (may burn). Wash your hands before and after use. Do not wash your hands after use if putting this on your hand. Clean affected part before use. Make sure to dry well. Put on the affected part as you have been told. You may need to cover the treated area with a bandage or dressing. Talk with the doctor. What do I do if I miss a dose? Put on a missed dose as soon as you think about it. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not put on 2 doses or extra doses. What are some side effects that I need to call my doctor about right away? WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect: Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat. Signs of skin infection like oozing, heat, swelling, redness, or pain. Fever. What are some other side effects of Silverseal Hydrogel Dressing? All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if you have any side effects that bother you or do not go away. These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch. Side Effects (complete list) If OVERDOSE is suspected: If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. How do I store and/or throw out Silverseal Hydrogel Dressing? Store at room temperature. Protect from light. Protect from heat. Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets. Check with your pharmacist about how to throw out unused drugs. Consumer Information Use and Disclaimer If your symptoms or health problems do not get better or if they become worse, call your doctor. Do not share your drugs with others and do not take anyone else's drugs. Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor. Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins. Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about this medicine, please talk with your doctor, nurse, pharmacist, or other health care provider. If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. This information should not be used to decide whether or not to take Silverseal Hydrogel Dressing or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to Silverseal Hydrogel Dressing. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine. Review Date: November 1, 2017 Next Side Effects Print this page Add to My Med List More about silver topical Side Effects Drug Interactions Support Group 6 Reviews Add your own review/rating Drug class: topical anti-infectives Consumer resources Silver Gel Silver Pads Related treatment guides Dermatological Disorders Drug Status Rx OTC Availability Rx and/or OTC N Pregnancy Category Not classified N/A CSA Schedule Not a controlled drug Silver topical Rating 6 User Reviews 9.3 /10 6 User Reviews 9.3 Rate it! Drug Class Topical anti-infectives Related Drugs Dermatological Disorders triamcinolone , clobetasol topical , betamethasone , Temovate , Diprolene , Analpram-HC , Celestone , urea topical , Clobex , Valisone , Proctofoam HC , hydroquinone topical , sodium hyaluronate topical , Olux , Betamethacot , Diprosone , salicylic acid topical , Melamin , Diprolene AF , Celestone Soluspan , Analpram E , Clobevate , More... with your


most desirable Silverseal Hydrogel Dressing weak spot
completing Dance Your Way to a Healthier Aging Brain to confess

completing Dance Your Way to a Healthier Aging Brain to confess

all at once Dance Your Way to a Healthier Aging Brain every so often
 
Photo :Dance Your Way to a Healthier Aging Brain

the precise (*this news item will not be available after 01/10/2018) Thursday, October 12, 2017 THURSDAY, Oct. 12, 2017 (HealthDay News) -- Dance classes may beat traditional exercise when it comes to improving older adults' balance -- and it might enhance brain areas related to memory and learning along the way. That's the finding of a small study that compared dance lessons against standard exercise -- including brisk walking -- among 52 healthy seniors. Over a year and a half, older adults who took weekly dance classes showed gains in their balancing ability. There were no such improvements in the traditional exercise group. Researchers also found hints that all those mambos and cha-chas had extra brain benefits. Seniors in both groups showed growth in the hippocampus -- a brain structure that's involved in memory and learning. But the dancers showed changes in more areas of the hippocampus. Patrick Muller, one of the researchers on the study, suggested an explanation: The "multimodal" nature of dance -- its physical and mental components -- might be behind the extra brain boost. Seniors in the dance group had to continually learn and "imprint" new steps, explained Muller, a Ph.D. candidate at the German Center for Neurodegenerative Diseases in Magdeburg, Germany. Along with that mental challenge, he said, dance also involves coordinating movement with music -- which itself affects the brain. Plus, there's the fun, Muller noted. David Marquez is an associate professor of kinesiology at the University of Illinois at Chicago. He said it's hard to know what to make of the brain findings, since the study group was so small. Marquez, who was not involved in the research, is studying the effects of Latin dance classes on older Hispanic adults' well-being. He agreed that dance can offer things that simpler repetitive activity may not. "With dance, you're having to think about each step," Marquez said. "There are motor, cognitive and social components. And there's the music." But, he added, both exercise groups in this study showed changes in the hippocampus, on average. And that's in line with past research, Marquez noted: Studies have found that regular aerobic exercise, like walking, may boost the volume of brain areas involved in memory, planning and other vital functions. "So the message is, get moving," Marquez said. Ultimately, he added, the "best" form of exercise for any one person is the one that can be maintained. "If you don't enjoy the activity, you won't do it," Marquez said. "So find something you enjoy and do it regularly." The study, published in Frontiers in Human Neuroscience , included healthy volunteers who were typically in their late 60s. Half were randomly assigned to take dance classes over 18 months. The rest attended a traditional exercise program that included walking, stationary bikes, strength-training and stretching. The dance group met twice a week for the first six months, then weekly. To keep participants on their toes, the dance styles changed every couple of weeks and ranged from Latin to line dancing to jazz. Just 14 seniors from the dance group and 12 from the traditional fitness group stayed with the program for the full 18 months. In the end, the study found, only the dancers showed clear improvements on balance tests. And while both groups had increases in their hippocampal volume, the dance group tended to show changes in more subregions of the hippocampus. The hippocampus is critical, according to Muller, because it is affected in dementia -- including Alzheimer's disease -- and it can also shrink with age. The big question, though, is whether dance can make any difference in the odds of seniors' mental decline. "Further research is needed to clarify whether this intervention truly has the potential to reduce the risk of neurodegenerative diseases such as Alzheimer's," Muller said. According to Marquez, it would be interesting to do the same study with older adults who already have some cognitive impairment, and see if there are similar brain changes. For now, Muller said, the findings suggest dance might have some advantages over simpler repetitive physical activity. But he agreed that exercise in general -- plus a healthy lifestyle overall -- "can help the brain stay young." SOURCES: Patrick Muller, Ph.D. candidate, German Center for Neurodegenerative Diseases, Magdeburg, Germany; David Marquez, Ph.D., associate professor, kinesiology and nutrition, University of Illinois at Chicago; June 2017, Frontiers in Human Neuroscience HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Exercise for Seniors Healthy Aging Recent Health News to break down


up to date Dance Your Way to a Healthier Aging Brain staff
place of job Silver Sulfadiazine stimulated

place of job Silver Sulfadiazine stimulated

for everybody Silver Sulfadiazine every now and then
 
Photo :Silver Sulfadiazine

napping Silver Sulfadiazine Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings User Reviews Support Group Q & A Pricing & Coupons Pronunciation (SIL ver sul fa DYE a zeen) Index Terms Silver Sulphadiazine Dosage Forms Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product Cream, External: Silvadene: 1% (20 g, 25 g, 50 g, 85 g, 400 g, 1000 g) [contains methylparaben, propylene glycol] SSD: 1% (25 g, 50 g, 85 g, 400 g) [contains cetyl alcohol, methylparaben, propylene glycol] Thermazene: 1% (20 g [DSC], 50 g [DSC], 85 g [DSC], 400 g [DSC], 1000 g [DSC]) [contains methylparaben, propylene glycol] Generic: 1% (20 g, 25 g, 50 g, 85 g, 400 g) Slideshow Type 1 Diabetes: Symptoms, Treatments, and Breakthroughs Brand Names: U.S. Silvadene SSD Thermazene [DSC] Pharmacologic Category Antibiotic, Topical Pharmacology Acts upon the bacterial cell wall and cell membrane. Bactericidal for many gram-negative and gram-positive bacteria and is effective against yeast. Active against Pseudomonas aeruginosa , Pseudomonas maltophilia , Enterobacter species, Klebsiella species, Serratia species, Escherichia coli , Proteus mirabilis , Morganella morganii , Providencia rettgeri , Proteus vulgaris , Providencia species, Citrobacter species, Acinetobacter calcoaceticus , Staphylococcus aureus , Staphylococcus epidermidis , Enterococcus species, Candida albicans , Corynebacterium diphtheriae , and Clostridium perfringens Absorption Negligible (superficial and deep burns and normal skin); increased absorption with blister removal (Sano 1982) Excretion Silver: Feces; slow excretion rate; Sulfadiazine: Urine (6.6% within 5 days) (Sano 1982) Half-Life Elimination Sulfadiazine: ~24 hours (Sano 1982) Use: Labeled Indications Burn treatment: As an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. Contraindications Hypersensitivity to silver sulfadiazine or any component of the formulation; pregnant women approaching or at term; premature infants or neonates 2 months of age. Documentation of allergenic cross-reactivity for drugs in this class is limited. However, because of similarities in chemical structure and/or pharmacologic actions, the possibility of cross-sensitivity cannot be ruled out with certainty. Dosing: Adult Burn treatment: Topical: Apply to a thickness of 1 / 16 inch once or twice daily; reapply as needed to areas where the cream is removed by patient activity as the burned area should be covered with cream at all times. Continue use until healing has occurred or the burn site is ready for grafting. Do not discontinue therapy if the possibility of infection exists unless a significant adverse reaction has occurred. Dosing: Geriatric Refer to adult dosing. Dosing: Pediatric Burn treatment: Infants 2 months, Children, and Adolescents: Refer to adult dosing. Dosing: Renal Impairment There are no dosage adjustments provided in the manufacturer's labeling; use with caution; drug accumulation may occur. Dosing: Hepatic Impairment There are no dosage adjustments provided in the manufacturer's labeling; use with caution; drug accumulation may occur. Administration For topical use only; avoid contact with eyes. Apply with a sterile-gloved hand. Burned area should be covered with cream at all times; reapply to areas where cream has been removed by patient activity. Dressings may be used if necessary. Reapply immediately after hydrotherapy. Storage Store at 20 C to 25 C (68 F to 77 F). Drug Interactions BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). Avoid combination BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). Monitor therapy Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Avoid combination Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. Consider therapy modification Test Interactions Propylene glycol may affect the interpretation of laboratory tests. Adverse Reactions Frequency not defined. Dermatologic: Erythema multiforme, pruritus, skin discoloration, skin photosensitivity, skin rash Hematologic & oncologic: Agranulocytosis, aplastic anemia, hemolytic anemia, leukopenia Hepatic: Hepatitis Hypersensitivity: Hypersensitivity reaction (may be related to sulfa component) Renal: Interstitial nephritis Warnings/Precautions Concerns related to adverse effects: Sulfonamide allergy: Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use in patients with sulfonamide allergy is specifically contraindicated in product labeling, however, a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe. Superinfection: Prolonged use may result in fungal or bacterial superinfection, including C. difficile -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed >2 months postantibiotic treatment. Fungal proliferation may rarely occur in and below the eschar. Systemic effects: Systemic absorption may be significant and adverse reactions may occur. Disease-related concerns: G6PD deficiency: Use with caution in patients with G6PD deficiency; hemolysis may occur. Hepatic impairment: Use with caution in patients with hepatic impairment; sulfadiazine may accumulate. Renal impairment: Use with caution in patients with renal impairment; sulfadiazine may accumulate. Concurrent drug therapy issues: Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information. Dosage form specific issues: Propylene glycol: Some dosage forms may contain propylene glycol; large amounts are potentially toxic and have been associated hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Zar 2007). Other warnings/precautions: Appropriate use: For topical use only. Avoid contact with eyes. Monitoring Parameters Serum electrolytes, urinalysis, renal function tests, CBC in patients with extensive burns on long-term treatment. Serum sulfa concentrations, if clinically indicated. Pregnancy Considerations Adverse events were not observed in animal reproduction studies. Because of the theoretical increased risk for hyperbilirubinemia and kernicterus, silver sulfadiazine is contraindicated for use near term, on premature infants, or on newborn infants during the first 2 months of life (refer to Sulfadiazine monograph). Patient Education Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?) Patient may experience skin discoloration. Have patient report immediately to prescriber signs of infection, signs of liver problems (dark urine, feeling tired, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin or eyes), hematuria, urinary retention, bruising, bleeding, severe loss of strength and energy, severe abdominal pain, severe skin irritation, or signs of Stevens-Johnson syndrome/toxic epidermal necrolysis (red, swollen, blistered, or peeling skin [with or without fever]; red or irritated eyes; or sores in mouth, throat, nose, or eyes) (HCAHPS). Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions. Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients. Next Interactions Print this page Add to My Med List More about silver sulfadiazine topical Side Effects During Pregnancy Dosage Information Drug Interactions Support Group Pricing & Coupons En Espaรฑol 49 Reviews Add your own review/rating Drug class: topical antibiotics Consumer resources Silver sulfadiazine topical Silver Sulfadiazine Silver sulfadiazine Topical (Advanced Reading) Professional resources Silver Sulfadiazine (AHFS Monograph) Silver Sulfadiazine Cream (FDA) Other brands: Silvadene , SSD , Thermazene Related treatment guides Burns, External} Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Silver sulfadiazine topical Rating 49 User Reviews 9.7 /10 49 User Reviews 9.7 Rate it! Manufacturer Ascend Laboratories LLC Drug Class Topical antibiotics Related Drugs topical antibiotics mupirocin topical , erythromycin topical , Bactroban , neomycin topical , gentamicin topical , bacitracin topical Burns, External lidocaine topical , vancomycin , gentamicin , tobramycin , Silvadene , Albutein , aloe vera topical , Vancocin , Xylocaine Jelly , benzocaine topical , sodium hyaluronate topical , Garamycin , albumin human , Xylocaine Topical , Tobi , Buminate , SSD , Lidocream , Dermoplast , Bionect , RadiaPlexRx , Albuminar-25 , AneCream , dibucaine topical , More...} } omitted


ingredient Silver Sulfadiazine the majority
out of practice Daily 'Light Therapy' May Help Some With Bipolar Disorder hit upon

out of practice Daily 'Light Therapy' May Help Some With Bipolar Disorder hit upon

for this reason Daily 'Light Therapy' May Help Some With Bipolar Disorder in recent times
 
Photo :Daily 'Light Therapy' May Help Some With Bipolar Disorder

46 (*this news item will not be available after 01/10/2018) By Robert Preidt Thursday, October 12, 2017 THURSDAY, Oct. 12, 2017 (HealthDay News) -- People afflicted with bipolar disorder may find some relief from depression with daily doses of light therapy, new research suggests. With light therapy, people spend time sitting in close proximity to a light-emitting box -- in this case, bright white light -- with exposures increasing from 15 minutes per day to a full hour over a period of weeks. The study found that within a month the therapy helped treat depression in people with bipolar disorder. "Effective treatments for bipolar depression are very limited," noted lead researcher Dr. Dorothy Sit. "This gives us a new treatment option for bipolar patients that we know gets us a robust response within four to six weeks," said Sit, who is associate professor of psychiatry at Northwestern University in Chicago. According to the Brain & Behavior Research Foundation, bipolar disorder "is a brain and behavior disorder characterized by severe shifts in a person's mood and energy, making it difficult for the person to function." Over 5.7 million Americans are thought to have the disorder, which often involves depressive episodes. As Sit's team noted, prior research had shown that morning light therapy reduces symptoms of depression in people with seasonal affective disorder (SAD), a condition where winter's reduced light spurs depression. However, it's also been noted that light therapy can sometimes cause side effects, such as mania, in people with bipolar disorder. Still, the Northwestern team wondered if the treatment might not have a role for bipolar patients with at least moderate depression who were also taking a mood stabilizer drug. In the study, 46 patients received either a 7,000 lux bright white light or a 50 lux light (acting as the "placebo arm" of the trial). The study participants were told to place the light box about one foot from their face for 15 minutes between noon and 2:30 p.m. each day at the start of the study. Over six weeks, the patients increased their light therapy "doses" in 15-minute increments until they reached a dose of 60 minutes per day -- or had a significant change in their mood. Compared with people in the placebo group, those in the treatment group were more likely to have significant improvements, Sit's team said. More than 68 percent of patients in the treatment group achieved a normal mood versus 22 percent of those in the placebo group, the findings showed. Patients in the treatment group also had a much lower average depression score than those in the placebo group, and significantly higher functioning, meaning they could return to work or complete household tasks they hadn't been able to finish before treatment. Significantly, none of the patients experienced mania or hypomania, a condition that includes a period of elation, euphoria, irritability, agitation, rapid speech, racing thoughts, a lack of focus and risk-taking behaviors. "As clinicians, we need to find treatments that avoid these side effects and allow for a nice, stable response. Treatment with bright light at midday can provide this," Sit said in a university news release. Two psychiatrists agreed that the therapy may have merit for patients, who often have few options. "No standard antidepressants are approved for treatment of bipolar depression," said Dr. Seth Mandel, who directs psychiatry at Northwell Health's Huntington Hospital in Huntington, N.Y. He added that antipsychotics that are approved for bipolar disorder often come with side effects that cause many patients to stop using them. Light therapy "offers us another option, one that certainly appears to do no harm," Mandel said. Still, he noted that patients with more severe symptoms weren't included in the Chicago study, and he also believes many people won't be able to adhere to the hour-long, daily dosage required. Dr. Ami Baxi is a psychiatrist who directs adult inpatient services at Lenox Hill Hospital in New York City. She agreed that light therapy may be "a welcome addition to our limited treatment options for bipolar depression." The study was funded by the U.S. National Institute of Mental Health and published Oct. 3 in the American Journal of Psychiatry . SOURCES: Seth Mandel, M.D., chairman of psychiatry, Northwell Health's Huntington Hospital, Huntington, N.Y.; Ami Baxi, M.D., director of adult inpatient services, Lenox Hill Hospital, New York City; Northwestern University, news release, Oct. 10, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Bipolar Disorder Recent Health News right now


eating healthy Daily 'Light Therapy' May Help Some With Bipolar Disorder secret agent
deplete Black Women Face Double the Risk of Pregnancy-Related Heart Failure finest

deplete Black Women Face Double the Risk of Pregnancy-Related Heart Failure finest

disregard Black Women Face Double the Risk of Pregnancy-Related Heart Failure the path
 
Photo :Black Women Face Double the Risk of Pregnancy-Related Heart Failure

requesting (*this news item will not be available after 01/11/2018) By Robert Preidt Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Black American women are twice as likely as women in other racial/ethnic groups to develop a form of pregnancy-related heart failure, a new study finds. Peripartum cardiomyopathy (PPCM) is a potentially life-threatening condition that can occur in the last month of pregnancy or up to five months following delivery. With this disorder the heart chambers enlarge and heart muscle weakens, leading to reduced blood flow that affects the lungs, liver and other organs. Researchers analyzed the medical records of 220 women diagnosed with PPCM. Black women with PPCM were younger (age 27 vs. 31), had more severe disease, and took longer to recover than white, Hispanic or Asian women. "Not only are African-American women at twice the risk, but in this study we found they also took twice as long to recover, they were twice as likely to worsen before getting better after diagnosis, and they were twice as likely to fail to recover altogether, meaning their heart failure persisted for months following delivery," said senior author Dr. Zoltan Arany in a University of Pennsylvania news release. He is an associate professor of cardiovascular medicine and director of the university's Cardiovascular Metabolism Program. The study "opens the door for even more research on this subject, to find out why these women are more at risk," study author Dr. Jennifer Lewey said. She's an assistant professor of cardiovascular medicine and director of the Penn Women's Cardiovascular Center. The researchers don't know why these differences occur. Lewey suggested the increased risk might be due to genetics, socioeconomic status or access to care. Or it could be due to medical problems such as high blood pressure. "Our next step will be to answer these questions, and identify how we can proactively diagnose and potentially prevent such a dangerous diagnosis in this at-risk patient population," Lewey said. The study was published in the Journal of the American Medical Association . SOURCE: University of Pennsylvania, news release, Oct. 11, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Health Disparities Heart Failure Recent Health News at present


captivating Black Women Face Double the Risk of Pregnancy-Related Heart Failure Best Microwave
advertising and marketing Need Cancer Screening? Where You Work Matters is essential

advertising and marketing Need Cancer Screening? Where You Work Matters is essential

fantastic Need Cancer Screening? Where You Work Matters is well known
 
Photo :Need Cancer Screening? Where You Work Matters

and adaptability (*this news item will not be available after 01/11/2018) By Robert Preidt Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Waiters, contractors and other employees of America's small businesses are more likely to miss out on cancer screening, mostly because of a lack of insurance, new research shows. "Workers employed at smaller organizations had substantially lower breast, cervical and colorectal cancer screening rates" compared to people working at larger corporations or organizations, American Cancer Society (ACS) researchers reported. And poorer insurance coverage accounted for much of these differences, said the team led by ACS researcher Stacey Fedewa. One breast cancer specialist who reviewed the findings said the issue is an important one, because mammograms, colonoscopies and other screens can save lives -- not to mention health care dollars. So it's crucial to "find ways to ensure that workers in smaller companies have access to health care," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. "This is a complicated problem, as some smaller businesses cannot afford to provide insurance to their workers due to the rising cost of premiums." In the new report, the ACS team tracked 2010, 2013 and 2015 federal government data. The investigators found that, overall, screening rates for U.S. workers were 84 percent for cervical cancer, about 69 percent for breast cancer and 57 percent for colon cancer. But those numbers fell precipitously for employees at companies with fewer than 25 workers -- they were much less likely be screened than those at companies with 500 or more workers. Fedewa's team also found that people in food service, construction, production and sales occupations were less likely to be up to date with cervical screening (26 percent less likely), breast screening (28 percent) and colon cancer screening (30 percent) than people working in the health care industry, for example. The differences in cancer screening rates among workers were mostly due to lower income and lack of insurance, the study authors said. Dr. Cynara Coomer directs the Comprehensive Breast Center at Staten Island University Hospital, in New York City. Reading over the findings, she agreed that a number of factors -- lack of insurance, transportation issues, education -- keep many Americans from cancer screening. "As health care professionals, we need to strive to educate all communities about the importance of screening for certain cancers," she said. "In addition, we need to find a solution to provide people of all socioeconomic levels access to medical care." The findings were published Oct. 13 in the journal Preventive Medicine . SOURCES: Stephanie Bernik, M.D., chief, surgical oncology, Lenox Hill Hospital, New York City; Cynara Coomer, M.D., director chief of breast surgery and director, Comprehensive Breast Center, Staten Island University Hospital, New York City; American Cancer Society, news release, Oct. 12, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Cervical Cancer Screening Health Screening Recent Health News a hundred and fortieth


might Need Cancer Screening? Where You Work Matters you actually
wade through Nearly 4 in 10 U.S. Adults Now Obese looking ahead to

wade through Nearly 4 in 10 U.S. Adults Now Obese looking ahead to

seriously Nearly 4 in 10 U.S. Adults Now Obese is celebrated
 
Photo :Nearly 4 in 10 U.S. Adults Now Obese

treatment plans (*this news item will not be available after 01/11/2018) Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Almost forty percent adults in the United States are now obese, continuing an ever-expanding epidemic of obesity that's expected to lead to sicker Americans and higher health care costs. Almost four out of 10 adults and 18.5 percent of kids aged 2 to 19 now meet the clinical definition of obesity, according to a new report from the U.S. Centers for Disease Control and Prevention. That's up from 30.5 percent of adults and 13.9 percent of children in 1999-2000, the CDC report noted. Public health experts are concerned that the continuing rise in obesity will lead to greater numbers of people suffering from diabetes, heart disease and other chronic illnesses. "We've made tremendous progress reducing deaths due to cardiovascular disease and stroke in our country. Part of that is due to treatment. Part of that is due to the tremendous reduction in tobacco use," said Dr. Eduardo Sanchez, chief medical officer for the American Heart Association. "But we've worried if obesity trends stayed or worsened that some of those gains might be reduced." Obesity is defined as a body mass index of 30 or more. A 6-foot-tall man weighing 221 pounds is considered obese, as is a 5-foot-9 woman weighing 203 pounds. The increase in youth obesity is of particular concern because these children are at greater risk for lifelong health problems, said Dr. Seema Kumar, a childhood obesity specialist with the Mayo Clinic. Kumar said she regularly sees children with diseases that used to be considered adult-only, including type 2 diabetes, high blood pressure, high cholesterol and fatty liver disease. "Because rates of obesity are so high, despite all the advances we're seeing, our children may live less healthy and shorter lives than their parents," Kumar said. "We're going to have a much higher number of adults with diabetes, high blood pressure and heart disease down the line." Some trends within the overall increase in obesity also have health experts worried. For example, Sanchez noted, obesity appears to be more prevalent in ethnic groups that are growing rapidly in the United States. About 47 percent of Hispanic and black adults are obese, compared with 38 percent of whites and 13 percent of Asians, the researchers found. "The demographic profile of our country is shifting in such a way that the burden of obesity will continue to grow unless we address these disparities," Sanchez said. "We're still going to be heading in a challenging direction." Diana Thomas, a fellow with The Obesity Society, pointed out that the rise in youth obesity also is likely to continue because obese adults tend to mate, reproduce more often, and produce children that also struggle with excess weight. "That next generation that's coming in with a high prevalence of obesity will probably continue to affect us in the future," said Thomas, who is a professor of mathematical sciences at West Point. Rates of obesity increase with age, the investigators found. Close to 43 percent of middle-aged adults are obese, compared with about 36 percent of younger adults, nearly 21 percent of teenagers and 14 percent of children aged 2 to 5. Stemming the obesity epidemic will involve action at both the personal and the community level, Sanchez and Kumar said. Family-based programs are available that teach young parents how to cook healthy meals, Kumar said. These programs teach healthy eating habits that kids will model once they see their parents setting an example. "If we can teach our families to eat healthy, that would probably be the most important thing we could do," Kumar said. Communities also play a crucial role. They can help by adopting policies that encourage a healthy diet and more physical activity, Sanchez suggested. These might include: Healthier food and drinks in vending machines in schools and businesses. Improving accessibility to healthy foods by promoting farmers' markets. Designing neighborhoods to be more walkable and bike-friendly. Promoting physical activity for kids both in and outside of school. "It's not just about giving people information," Sanchez said. "It's about helping individuals and their families adopt different behaviors, and make it easier for them to do so." The report, by Dr. Craig Hales and colleagues at the National Center for Health Statistics (NCHS), was published in the October issue of the CDC's NCHS Data Brief . SOURCES: Eduardo Sanchez, M.D., MPH, chief medical officer, American Heart Association; Seema Kumar, M.D., childhood obesity specialist, Mayo Clinic, Rochester, Minn.; Diana Thomas, Ph.D., fellow, Obesity Society and professor, mathematical sciences, West Point, N.Y.; Oct. 13, 2017, NCHS Data Brief HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Obesity Obesity in Children Weight Control Recent Health News cost


really Nearly 4 in 10 U.S. Adults Now Obese surgical operation
and give the opportunity More Women Choose Breast Reconstruction After Mastectomy absolutely everyone

and give the opportunity More Women Choose Breast Reconstruction After Mastectomy absolutely everyone

the jobs More Women Choose Breast Reconstruction After Mastectomy demanding
 
Photo :More Women Choose Breast Reconstruction After Mastectomy

equipment (*this news item will not be available after 01/11/2018) By Robert Preidt Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows. An analysis of patient data shows breast reconstruction followed 40 percent of breast-removal surgeries in 2014 -- up from less than one-quarter in 2009, according to the U.S. Agency for Healthcare Research and Quality (AHRQ). Among age groups, women aged 65 and older accounted for the largest increase in breast reconstructive surgery -- 140 percent. "This type of information is essential for policymakers and health systems seeking to keep pace with important trends in clinical care," Gopal Khanna, agency director, said in an AHRQ news release. The overall increase during the study period was 65 percent, researchers said. While reconstruction procedures increased in all insurance groups, the jump was highest for Medicare patients. Even so, the Medicare reconstruction rate was lowest -- 19 reconstructions per 100 mastectomies -- compared to other insurance plans. A dramatic rise in reconstruction surgeries also occurred among women without insurance, the data from 22 states revealed. "This information suggests that many uninsured women were willing to pay for reconstruction surgery out of pocket," said Anne Elixhauser, a senior scientist at the agency. Medical, sexual and physical concerns come into play when deciding for or against breast reconstruction, according to the report. "Medical considerations include concerns that breast reconstruction surgery lengthens recovery time and increases the chance for infection and other postoperative complications," the authors say. "Sexual considerations involve the impact of the mastectomy on future sexual encounters. Physical features include how breasts may define femininity and sense of self," they noted. Other notable findings: Most of the growth in reconstructive procedures occurred in hospital-based outpatient surgical centers (150 percent increase). The rate for inpatient reconstructions remained unchanged. In 2014, reconstruction surgery was less common among women in rural areas than among those in cities. Black women were more likely to undergo breast reconstruction surgery in an inpatient setting and along with mastectomy than white and Hispanic women. SOURCE: Agency for Healthcare Research and Quality, news release, Oct. 10, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Breast Reconstruction Mastectomy Women's Health Recent Health News and you are going


definitely More Women Choose Breast Reconstruction After Mastectomy mastering
Baron Verulam Black Children Missing Out on Eczema Treatment commonly

Baron Verulam Black Children Missing Out on Eczema Treatment commonly

commonly Black Children Missing Out on Eczema Treatment of 1
 
Photo :Black Children Missing Out on Eczema Treatment

off form (*this news item will not be available after 01/11/2018) By Mary Elizabeth Dallas Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Black children may have more severe eczema than white children, but they are less likely to visit a doctor for this common inflammatory skin condition, new research shows. Eczema causes the skin to become red and itchy. Roughly 11 percent of children in the United States are affected by the condition, according to the U.S. Centers for Disease Control and Prevention. "Previous studies have demonstrated disparities in overall health care utilization among racial and ethnic minorities, but few studies have examined this question specifically for eczema," said senior study author Dr. Junko Takeshita. She is an assistant professor of dermatology and epidemiology at the University of Pennsylvania's Perelman School of Medicine. "This is the first study to look at racial and ethnic differences in health care utilization for eczema on an individual level rather than relying on a sample of outpatient visits, making this a unique evaluation of eczema that includes those not accessing care for their disease," she said in a Penn news release. The study included health care data on a group of more than 2,000 children and teens under 18 with eczema. The data was collected from 2001 and 2013. Based on their analysis, the researchers estimated that 66 percent of the nearly 3 million children with eczema are white, 18 percent are black and 16 percent are Hispanic. Overall, about 60 percent of these children have been treated for their condition but the odds of being treated by a doctor also varies by race, the researchers found. Among the white children with eczema, about 62 percent visited a doctor for the condition. Roughly 58 percent of Hispanic kids with the condition were also treated, compared to just 52 percent of black children. Overall, black children and teens with eczema are 30 percent less likely to see a doctor than white kids, the researchers calculated. Those who do see a doctor for eczema however tend to have more office visits and receive more prescriptions than white children, suggesting they have more severe cases of the condition, the researchers said. "The data show that race alone can be a predictor of whether or not a child with eczema will see a doctor, independent of other social or demographic factors or insurance status," Takeshita said. Minority children with eczema also tended to be younger. They were more likely to also have asthma than the white children with the condition. The minority children were also less likely to have private insurance and more likely to come from low-income homes. "While the study is not without its limitations, our findings suggest there are barriers to health care for eczema among black children, irrespective of income and insurance status, despite likely having more severe skin disease," Takeshita said. "Further research is needed to understand what these barriers are and why they exist so that we can ultimately make efforts to eliminate this disparity," she added. The study was published recently in the Journal of the American Academy of Dermatology . SOURCE: University of Pennsylvania Perelman School of Medicine, news release, September 29, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on African American Health Eczema Health Disparities Recent Health News the infant


was firm Black Children Missing Out on Eczema Treatment adjustments
the suitable Around the World, Too Little Relief for Pain another

the suitable Around the World, Too Little Relief for Pain another

the wonderful thing about Around the World, Too Little Relief for Pain undoubtedly
 
Photo :Around the World, Too Little Relief for Pain

to fifteen (*this news item will not be available after 01/11/2018) By Robert Preidt Friday, October 13, 2017 FRIDAY, Oct. 13, 2017 (HealthDay News) -- Tens of millions of people worldwide who die in severe physical and mental distress each year could have an easier death if low-cost pain drugs were available in their countries, a new report says. Children account for more than 2.5 million of the almost 26 million people with serious illnesses who receive no palliative care or pain relief, according to the report. The findings came from an analysis of data on the care provided in 172 countries for people with any of 20 serious conditions, including HIV, cancer, heart disease, premature birth, tuberculosis, hemorrhagic fevers, lung and liver disease, malnutrition, dementia and trauma injuries. Of the 61 million people who endure severe physical or psychological suffering and pain each year, about 83 percent live in 100 low- and middle-income countries where there's little or no access to low-cost, off-patent morphine, according to the report, issued by The Lancet Commission on Global Access to Palliative Care and Pain Relief. In high-income countries, the drugs costs 3 cents per 10-milligram dose, but the commission noted that in low-income nations, that amount costs 16 cents, where and when it's available. The report further noted that just 10.8 metric tons (3.6 percent) of the 298.5 metric tons of oral morphine distributed worldwide go to low- and middle-income countries. The commission's report appears Oct. 13 in The Lancet medical journal. "The pain gap is a massive global health emergency which has been ignored, except in rich countries," commission chair Felicia Knaul, a professor at the University of Miami Miller School of Medicine, said in a journal news release. "This global pain crisis can be remedied quickly and effectively," she said. "We have the right tools and knowledge and the cost of the solution is minimal. Denying this intervention is a moral failing, especially for children and patients at the end of life. "If low- and middle-income countries could obtain morphine at the same price as rich countries, the annual global price tag for closing the gap in access to oral morphine would be $145 million, a fraction of the cost of running a medium-sized U.S. hospital," Knaul said. "This is a pittance compared to $100 billion a year that the world's governments spend on enforcing global prohibition of drug use," she added. "The biggest shame is children in low-income countries dying in pain, which could be eliminated for $1 million a year," Knaul said. The problem is greatest in eight countries with the highest populations: China, India, Pakistan, Nigeria, Bangladesh, Russia and Mexico, the report said. "We can ensure that the 61 million people a year who need it get palliative care," Knaul said. "The alternative is unacceptable and unthinkable." SOURCE: The Lancet , news release, Oct. 12, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Medicines Pain Recent Health News comprehend


treatment plans Around the World, Too Little Relief for Pain you might have considered trying
place of work With Skin Cancer Surgery, Insurance Matters footage

place of work With Skin Cancer Surgery, Insurance Matters footage

a wider variety With Skin Cancer Surgery, Insurance Matters could be
 
Photo :With Skin Cancer Surgery, Insurance Matters

a method (*this news item will not be available after 01/14/2018) By Mary Elizabeth Dallas Monday, October 16, 2017 MONDAY, Oct. 16, 2017 (HealthDay News) -- Surgery is the main treatment for melanoma -- a dangerous form of skin cancer -- but a patient's insurance could affect whether or not that cancer is quickly removed, new research suggests. After reviewing thousands of melanoma cases, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center reported that patients with Medicaid were more likely to face delays in scheduling their surgery than those with private insurance. Medicaid is the federally funded health insurance program for poor and needy people. "The primary treatment for most melanoma is surgical excision, which can be curative," said study author Dr. Ade Adamson, a clinical instructor in the UNC School of Medicine's department of dermatology. "These delays in care are concerning, particularly if they disproportionately affect those who might be the most vulnerable, such as Medicaid patients," he said in a hospital news release. Researchers reviewed the records of almost 8,000 patients from North Carolina. All had been diagnosed with melanoma between 2004 and 2011. Patients had private health insurance, Medicaid or Medicare, the health insurance program for those 65 and older. Specifically, the study examined the amount of time between the patients' diagnoses and their surgery. The study showed that the patients with Medicaid were 36 percent more likely than those with private insurance to experience surgical delays. Folks with Medicaid were also more likely to wait more than six weeks for their surgery after being told that they had melanoma. Delays were also more common among patients who were not white. The patients least likely to wait for melanoma surgery were those with private insurance. Those who were diagnosed or operated on by a dermatologist were also less likely to face surgical delays, according to the findings. The researchers noted that Medicaid patients often lack access to dermatologists and may have trouble getting referrals for specialists, which could increase their risk for delays. "We have identified insurance type as a factor associated with timeliness of care delivered to patients with melanoma," said Dr. Nancy Thomas, chair of the School of Medicine's department of dermatology. The authors said more research is needed to determine what is causing the delays in melanoma surgery. "Once we figure this out we can think about ways to construct an intervention to make sure patients with this potentially deadly cancer get the timely, appropriate care they deserve," Adamson said. The study was published in JAMA Dermatology . SOURCE: UNC Lineberger Comprehensive Cancer Center, news release, Oct. 4, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Health Disparities Health Insurance Melanoma Recent Health News stressful


more healthy With Skin Cancer Surgery, Insurance Matters the infant
giving freely Plan an Allergy-Safe Halloween for Your Child keep in mind that

giving freely Plan an Allergy-Safe Halloween for Your Child keep in mind that

given that Plan an Allergy-Safe Halloween for Your Child chronic
 
Photo :Plan an Allergy-Safe Halloween for Your Child

of what is (*this news item will not be available after 01/12/2018) By Alan Mozes Saturday, October 14, 2017 SATURDAY, Oct. 14, 2017 (HealthDay News) -- Halloween's frights extend beyond goblins and ghouls if you're a child with food allergies or asthma. "You want Halloween to be scary for the right reasons -- ghosts, goblins and witches -- not allergies and asthma," said allergist Dr. Stephen Tilles, president of the American College of Allergy, Asthma and Immunology. "If you follow a few common-sense rules, you should be able to keep your kids safe and the party going without allergy and asthma symptoms," he said in an association news release. Here, Tilles offers parents tips on how to limit the risk of allergic reactions: Don't let children consume any candy that isn't clearly labeled for indications of potential allergens. Have them bring all goodies home for you to inspect, or drop off safe treats for your child with friends and at school. Does your child have asthma? Keep an inhaler on hand while trick-or-treating, in case of exposure to smoke machines or mold while running door to door. A child who wheezes might also do better with a hat than a mask. Pay attention to costuming. For example, children who struggle with a metal allergy might do well to wear gloves. And for those at risk for eczema, use only hypoallergenic makeup, or avoid makeup altogether. Also, read garment labels to avoid materials such as latex that could pose a problem. A teal-colored pumpkin on the doorstep is considered an indicator of food allergy awareness. This lets others know that that particular household will provide a nonfood trick-or-treat alternative. SOURCE: American College of Allergy, Asthma and Immunology, news release HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Asthma in Children Child Safety Recent Health News obligations


your place Plan an Allergy-Safe Halloween for Your Child is making an attempt
lack of understanding Homicides Devastate Black Communities, But Prevention Gets Little Funding seems

lack of understanding Homicides Devastate Black Communities, But Prevention Gets Little Funding seems

sound asleep Homicides Devastate Black Communities, But Prevention Gets Little Funding travelers
 
Photo :Homicides Devastate Black Communities, But Prevention Gets Little Funding

deadlock (*this news item will not be available after 01/14/2018) By Robert Preidt Monday, October 16, 2017 MONDAY, Oct. 16, 2017 (HealthDay News) -- Homicide is the leading cause of early death among black Americans, a new study points out. Yet killings in the United States gets a disproportionately low share of federal research funding compared to the leading causes of death among whites, said study author Molly Rosenberg. "Homicide is, unfortunately, a common cause of premature death, and black Americans are more likely to be affected by homicide than white Americans," said Rosenberg. She is an assistant professor at Indiana University School of Public Health-Bloomington. "Homicide-related deaths in America, most of which are caused by firearms, constitute a public health crisis," Rosenberg said in a university news release. "Yet when we look at what kind of public health research gets funded and published, we find homicide to be conspicuously absent," she added. Rosenberg and her colleagues evaluated the leading causes of death in 2015 by race in the United States. They also looked at publicly funded research projects. Among whites, homicide is the 12th leading cause of early death, or potential years of life lost. This refers to the number of years people would have lived had they not died of a particular cause. The researchers found that heart disease -- the top cause of potential years of life lost among whites -- received 341 grants and almost 600 publications during 2015. Research on homicide, on the other hand, garnered just a handful of federal grants and publications, the study authors noted. "Homicide research is dramatically under-represented in public health research in terms of grant funding and publications. This lack of investment threatens to perpetuate a system that disadvantages the health of black Americans," Rosenberg said. "The more premature a death, the greater the loss in economic productivity for the family, community and society. This loss of human potential can push families into poverty and societies toward heightened inequality," she added. The study also found differences between blacks and whites in the potential years of life lost to all causes of death. For example, the average age of death from a birth defect was 15 years among blacks and 26 years among whites. And suicides occurred 10 years earlier on average among blacks -- at 38, versus 48 years of age among whites, according to the study. Overall, the more than 2.7 million deaths in the United States in 2015 resulted in nearly 21.4 million potential years of life lost. Blacks accounted for 20 percent of these years even though they make up only 13 percent of the U.S. population, the researchers explained. The study was published Oct. 10 in the journal PLoS One . SOURCE: Indiana University, news release, Oct. 10, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on African American Health Health Disparities Recent Health News large


by the way Homicides Devastate Black Communities, But Prevention Gets Little Funding traditional
suitable Nearly a Third of College Kids Think ADHD Meds Boost Grades work out

suitable Nearly a Third of College Kids Think ADHD Meds Boost Grades work out

taillights Nearly a Third of College Kids Think ADHD Meds Boost Grades be at liberty
 
Photo :Nearly a Third of College Kids Think ADHD Meds Boost Grades

a pretty big (*this news item will not be available after 01/14/2018) Monday, October 16, 2017 MONDAY, Oct. 16, 2017 (HealthDay News) -- Many college students who abuse ADHD drugs mistakenly believe that doing so will lead to better grades, a new survey suggests. Past research has found that college students commonly misuse stimulant medications such as Ritalin and Adderall as "study aids." That's despite the fact that there is no evidence the drugs help kids who do not have attention-deficit hyperactivity disorder (ADHD). The new study said that roughly 29 percent of students at nine U.S. colleges thought that stimulant medications boost school performance. Many others -- 38 percent -- were "unsure." And that misperception was especially common among students who admitted to abusing the drugs. Just over 11 percent said they'd used stimulant medication for "non-medical" reasons in the past six months. And of that group, almost two-thirds believed the drugs would improve their grades. The findings came as no surprise to Dr. Jess Shatkin, a professor of child and adolescent psychiatry at NYU Langone Medical Center, in New York City. But they do highlight an ongoing issue, according to Shatkin, who wasn't involved in the study. "When kids do not actually have ADHD, these drugs are not helpful for their school performance," Shatkin said. More concerning, he said, are the risks of misusing the medications -- such as altered heart rate and blood pressure, insomnia, heightened anxiety, and even hallucinations. "So no, we do not want students abusing these drugs," Shatkin said. How do you stop them? It's possible, according to Shatkin, that if more college kids are aware of the reality -- that their grades will not see a Ritalin-fueled rise -- then fewer will try the drugs. But, he said, the medications are effective at one thing: Helping harried college students stay up later. "So they'll at least finish that paper that's due tomorrow -- even if they won't get better grades," Shatkin said. It all points to wider issues, according to Shatkin: Many college students need help with basics like time management, dealing with stress, and knowing how to generally take care of themselves. Dr. Matthew Lorber is director of child and adolescent psychiatry at Lenox Hill Hospital, in New York City. He said stimulant abuse is a common problem not just among college students, but high school kids as well. When Lorber prescribes stimulants for children with ADHD, he encourages parents to "hold on" to the drugs themselves. That will limit the chances of their child sharing the drugs with their friends. He also counsels teens on the risks of medication-sharing once they are on their own at college. "We need to be discussing the dangers of these drugs for people who don't have ADHD," said Lorber, who wasn't part of the study team. The findings are based on a survey of almost 7,300 college students. None had ever been diagnosed with ADHD. Overall, students who believed that stimulants improve school performance were 2.5 times more likely to abuse the drugs, versus their peers who were "unsure." And students in that unsure group were about twice as likely to misuse stimulants as those who did not believe the medications helped with grades. Like Shatkin, Lorber said that trying to disabuse kids of that notion is unlikely to be enough. "But," he said, "it's information they should have -- along with information on the risks of misusing stimulants." He encouraged parents to talk to their kids about those dangers, just as they would when it comes to alcohol or illegal drugs. Shatkin recommended the discussions be even broader than that. "What do you do when you're depressed? What do you do when you're stressed? We often don't have these conversations with kids," he said. Shatkin also suggested that parents be mindful about how much pressure they put on their kids to succeed at school. "We don't want them to catastrophize over every grade," he said. The study was published earlier this year in the journal Addictive Behaviors . SOURCES: Matthew Lorber, M.D., director, child and adolescent psychiatry, Lenox Hill Hospital, New York City; Jess Shatkin, M.D., M.P.H., professor, child and adolescent psychiatry, NYU Langone Medical Center, New York City; July 14, 2017, Addictive Behaviors , online HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Attention Deficit Hyperactivity Disorder College Health Prescription Drug Abuse Recent Health News of what's


stoning up Nearly a Third of College Kids Think ADHD Meds Boost Grades ward off
making the most of When Should You Rush Your Toddler to the ER? wind up

making the most of When Should You Rush Your Toddler to the ER? wind up

lower your expenses When Should You Rush Your Toddler to the ER? understand that
 
Photo :When Should You Rush Your Toddler to the ER?

day off (*this news item will not be available after 01/14/2018) By Robert Preidt Monday, October 16, 2017 MONDAY, Oct. 16, 2017 (HealthDay News) -- Many American parents aren't sure when to rush their child to the emergency room, a new survey finds. "When young children experience urgent medical situations, parents have to make decisions about whether to administer first aid at home, call for advice or seek emergency care," said Dr. Gary Freed, from the University of Michigan. He is co-director of the C.S. Mott Children's Hospital Poll on Children's Health. "Our report suggests that some parents may be using the ER for common situations that could be handled at home," Freed said in a university news release. "Determining what is in fact an 'emergency' can be a confusing and nerve-wracking experience for parents who want to make the right decision." Researchers questioned nearly 400 parents with at least one child aged 5 or younger. They found only half would know what to do if their child was choking, 10 percent would take their child to the ER for a minor burn from a hot pan, and nearly one-third would take their child to the ER for swallowed pills. But going to the ER may do more harm than good in certain situations. For example, a child who is choking requires immediate help instead of waiting for treatment at the ER, Freed explained. The poll found that 8 percent of parents would go directly to the ER if their child were choking, while 29 percent said they would call 911. Others faced with choking would use methods such as the Heimlich maneuver (69 percent) to try to dislodge the object or try to remove the object with their finger (54 percent). Nearly half said they would hit the child on the back, while one-quarter would turn the child upside down. If their child swallowed medication not meant for them, more than half of parents said they would try to remove any pills from the child's mouth and one-quarter would make the child throw up. Six out of 10 said they would call Poison Control, while one-quarter would call their child's doctor. Twenty-six percent would call 911, and almost one-third would rush the child to the ER. "Generally, calling Poison Control is an excellent first step to take if a parent suspects their child swallowed something harmful," Freed said. "Poison Control staff are trained to get important information from parents about the type of medication their child might have swallowed and direct them on the next steps to take," he said. Parents who rush to the ER might forget to bring the source of the possible poisoning, leaving ER providers with limited information to determine the child's treatment, he added. The poll highlights the need for parents to get first aid training. The 43 percent of parents with no first aid training were less confident in making decisions about urgent situations than those with training. Just 10 percent of parents had received first aid training within the past year; 24 percent were trained within the past five years, and 23 percent had training more than five years ago. "In some cases, such as a small burn, parents would likely be able to consult a first aid resource to guide their response. Other situations, like choking, are clearly more time-sensitive and require immediate action. First aid training can help parents stay calm and manage the situation more effectively," Freed said. SOURCE: University of Michigan, news release, Oct. 16, 2017 HealthDay Copyright (c) 2017 HealthDay . All rights reserved. News stories are written and provided by HealthDay and do not reflect federal policy, the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, or the U.S. Department of Health and Human Services. More Health News on Emergency Medical Services Parenting Recent Health News enterprise


hiking When Should You Rush Your Toddler to the ER? anxious train
out of practice Silver Sulfadiazine every now and then

out of practice Silver Sulfadiazine every now and then

in good shape Silver Sulfadiazine no need
 
Photo :Silver Sulfadiazine

exquisite Silver Sulfadiazine Generic Name: Silver Sulfadiazine (SIL ver sul fa DYE a zeen) Brand Name: Silvadene, SSD, Thermazene Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings User Reviews Support Group Q & A Pricing & Coupons Uses of Silver Sulfadiazine: It is used to avoid or treat skin infections in patients with burns. It may be given to you for other reasons. Talk with the doctor. Slideshow Understanding Insulin: What You Need To Know What do I need to tell my doctor BEFORE I take Silver Sulfadiazine? For all patients taking silver sulfadiazine: If you have an allergy to silver sulfadiazine or any other part of this medicine. If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you are pregnant and near term. If you are breast-feeding or plan to breast-feed. Children: If your child is a premature baby or is a newborn. Do not give silver sulfadiazine to a premature baby or a newborn. If your child is younger than 2 months of age. Do not give this medicine to an infant younger than 2 months of age. This medicine may interact with other drugs or health problems. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take silver sulfadiazine with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. What are some things I need to know or do while I take Silver Sulfadiazine? Tell all of your health care providers that you take this medicine. This includes your doctors, nurses, pharmacists, and dentists. If you have a sulfa (sulfonamide) allergy, talk with your doctor. Be careful if you have G6PD deficiency. Anemia may happen. You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun. Do not use longer than you have been told. A second infection may happen. This medicine may cause harm if swallowed. If silver sulfadiazine is swallowed, call a doctor or poison control center right away. This medicine may affect certain lab tests. Be sure your doctor and lab workers know you use this medicine. Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using silver sulfadiazine while you are pregnant. How is this medicine (Silver Sulfadiazine) best taken? Use this medicine as ordered by your doctor. Read all information given to you. Follow all instructions closely. Do not take silver sulfadiazine by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn). Use as you have been told, even if your signs get better. Wash your hands before and after use. Do not wash your hands after use if putting this on your hand. Wear special gloves while putting this medicine on. Clean affected part and take off dead skin. Put a thin layer on the affected part and rub in gently. Put on 1 or 2 times a day or as you have been told by the doctor. Use a dressing if needed. What do I do if I miss a dose? Put on a missed dose as soon as you think about it. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not put on 2 doses or extra doses. Dosage Information (comprehensive) What are some side effects that I need to call my doctor about right away? WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect: Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat. Signs of infection like fever, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, or wound that will not heal. Signs of liver problems like dark urine, feeling tired, not hungry, upset stomach or stomach pain, light-colored stools, throwing up, or yellow skin or eyes. Blood in the urine. Not able to pass urine. Any unexplained bruising or bleeding. Feeling very tired or weak. Very bad belly pain. Very bad skin irritation. A very bad skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis) may happen. It can cause very bad health problems that may not go away, and sometimes death. Get medical help right away if you have signs like red, swollen, blistered, or peeling skin (with or without fever); red or irritated eyes; or sores in your mouth, throat, nose, or eyes. What are some other side effects of Silver Sulfadiazine? All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away: Change in color of skin. Skin irritation. These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch. Side Effects (complete list) If OVERDOSE is suspected: If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. How do I store and/or throw out Silver Sulfadiazine? Store at room temperature. Protect from heat. Store in a dry place. Do not store in a bathroom. Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets. Check with your pharmacist about how to throw out unused drugs. Consumer Information Use and Disclaimer If your symptoms or health problems do not get better or if they become worse, call your doctor. Do not share your drugs with others and do not take anyone else's drugs. Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor. Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins. Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about silver sulfadiazine, please talk with your doctor, nurse, pharmacist, or other health care provider. If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. This information should not be used to decide whether or not to take this medicine or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about silver sulfadiazine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using silver sulfadiazine. Review Date: November 1, 2017 Next Side Effects Print this page Add to My Med List More about silver sulfadiazine topical Side Effects During Pregnancy Dosage Information Drug Interactions Support Group Pricing & Coupons En Espaรฑol 49 Reviews Add your own review/rating Drug class: topical antibiotics Consumer resources Silver sulfadiazine topical Silver sulfadiazine Topical (Advanced Reading) Other brands: Silvadene , SSD , Thermazene , SSD AF Professional resources Silver Sulfadiazine (AHFS Monograph) Silver Sulfadiazine Cream (FDA) Silver Sulfadiazine (Wolters Kluwer) Related treatment guides Burns, External} Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Silver sulfadiazine topical Rating 49 User Reviews 9.7 /10 49 User Reviews 9.7 Rate it! Manufacturer Ascend Laboratories LLC Drug Class Topical antibiotics Related Drugs Burns, External lidocaine topical , vancomycin , gentamicin , tobramycin , Silvadene , Albutein , aloe vera topical , Vancocin , Xylocaine Jelly , benzocaine topical , sodium hyaluronate topical , Garamycin , albumin human , Xylocaine Topical , Tobi , SSD , Buminate , Lidocream , Dermoplast , Bionect , RadiaPlexRx , Albuminar-25 , AneCream , dibucaine topical , More...} } most dear


remedies Silver Sulfadiazine that offer
associates SM Allergy Multi-Symptom music

associates SM Allergy Multi-Symptom music

the best SM Allergy Multi-Symptom remedies
 
Photo :SM Allergy Multi-Symptom

exercise SM Allergy Multi-Symptom Generic Name: Acetaminophen, Chlorpheniramine, and Phenylephrine Tablets (ah seet ah MIN oh fen, klor fen EER a meen, & fen ill EF rin) Brand Name: Allergy Multi-Symptom, Allergy Multi-Symptom Daytime, Comtrex Flu Therapy Day/Night, Comtrex Severe Cold & Sinus, Contac Cold+Flu Maximum Strength, ...show all 36 brand names. Contac Cold/Flu Day & Night, Coricidin D Cold/Flu/Sinus, CVS Sinus Congestion/Pain Day/Night, CVS Sinus Congestion/Pain Night Time, Dristan Cold, EQ Allergy Relief, EQL Allergy Multi-Symptom, GNP Allergy Multi-Symptom, GNP Sinus Congestion/Pain Day/Night, GNP Sinus Congestion/Pain Night Time, GNP Sinus Relief Congestion/Pain, Medicidin-D, Night Time Sinus/Pain, Norel AD, Onset Forte, PX Allergy Sinus PE, QC Allergy Relief Multi-Symptom, RA Allergy Multi-Symptom, RA Sinus Congestion/Pain Day/Night, Robitussin Peak Cold Nasal Relief, SB Allergy Multi-Symptom, SB Sinus Congestion/Pain Day/Night, SB Sinus Congestion/Pain Night Time, Sinus Congestion/Pain Day/Night, Sinus Congestion/Pain Night Time, SM Allergy Multi-Symptom, Super Cold Tabs, Super Strength Sinadrin, TGT Sinus Congestion/Pain, Tylenol Allergy Multi-Symptom, Tylenol Sinus Congestion/Pain Overview Side Effects Dosage Interactions Reviews More Support Group Q & A Uses of SM Allergy Multi-Symptom: It is used to treat nose stuffiness. It is used to ease allergy signs. It is used to ease pain and fever. Slideshow OTC Medication Use In Pregnancy: Wise or Worrisome? What do I need to tell my doctor BEFORE I take SM Allergy Multi-Symptom? If you have an allergy to SM Allergy Multi-Symptom (acetaminophen, chlorpheniramine, and phenylephrine tablets) or any part of this medicine. If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking SM Allergy Multi-Symptom within 14 days of those drugs can cause very bad high blood pressure. This is not a list of all drugs or health problems that interact with this medicine. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take SM Allergy Multi-Symptom with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. What are some things I need to know or do while I take SM Allergy Multi-Symptom? Tell all of your health care providers that you take this medicine. This includes your doctors, nurses, pharmacists, and dentists. Do not take more than what your doctor told you to take. Taking more than you are told may raise your chance of very bad side effects. Do not take SM Allergy Multi-Symptom for longer than you were told by your doctor. Avoid driving and doing other tasks or actions that call for you to be alert until you see how this medicine affects you. Avoid drinking alcohol while taking SM Allergy Multi-Symptom. Talk with your doctor before you use other drugs and natural products that slow your actions. Use with care in children. Talk with the doctor. Avoid other sources of acetaminophen. Check labels closely. Too much acetaminophen may cause problems. Very bad and sometimes deadly liver problems have happened with the use of acetaminophen. Some people needed a liver transplant. Liver problems happened most often in people taking more than 4,000 mg (milligrams) in a day. People were often taking more than one drug with acetaminophen in it. Talk with your doctor. Call your doctor right away if you take more than 4,000 mg (milligrams) of acetaminophen in a day, even if you feel well. This medicine may affect certain lab tests. Tell all of your health care providers and lab workers that you take this medicine. Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using SM Allergy Multi-Symptom while you are pregnant. Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby. How is this medicine (SM Allergy Multi-Symptom) best taken? Use this medicine as ordered by your doctor. Read all information given to you. Follow all instructions closely. Take with or without food. Take with food if it causes an upset stomach. What do I do if I miss a dose? If you take SM Allergy Multi-Symptom on a regular basis, take a missed dose as soon as you think about it. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not take 2 doses at the same time or extra doses. Many times this medicine is taken on an as needed basis. Do not take more often than told by the doctor. Dosage Information (comprehensive) What are some side effects that I need to call my doctor about right away? WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect: Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat. Signs of liver problems like dark urine, feeling tired, not hungry, upset stomach or stomach pain, light-colored stools, throwing up, or yellow skin or eyes. Not able to pass urine or change in how much urine is passed. A very bad skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis) may happen. It can cause very bad health problems that may not go away, and sometimes death. Get medical help right away if you have signs like red, swollen, blistered, or peeling skin (with or without fever); red or irritated eyes; or sores in your mouth, throat, nose, or eyes. What are some other side effects of SM Allergy Multi-Symptom? All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away: Dizziness. Feeling nervous and excitable. Not able to sleep. Feeling sleepy. These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch. Side Effects (complete list) If OVERDOSE is suspected: If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. How do I store and/or throw out SM Allergy Multi-Symptom? Store at room temperature. Store in a dry place. Do not store in a bathroom. Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets. Check with your pharmacist about how to throw out unused drugs. Consumer Information Use and Disclaimer If your symptoms or health problems do not get better or if they become worse, call your doctor. Do not share your drugs with others and do not take anyone else's drugs. Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor. Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins. Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about SM Allergy Multi-Symptom (acetaminophen, chlorpheniramine, and phenylephrine tablets), please talk with your doctor, nurse, pharmacist, or other health care provider. If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. This information should not be used to decide whether or not to take this medicine or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about SM Allergy Multi-Symptom. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using SM Allergy Multi-Symptom. Review Date: November 1, 2017 Next Side Effects Print this page Add to My Med List More about acetaminophen/chlorpheniramine/phenylephrine Side Effects Dosage Information Drug Interactions Support Group En Espaรฑol 8 Reviews Add your own review/rating Drug class: upper respiratory combinations Consumer resources Acetaminophen, chlorpheniramine, and phenylephrine Acetaminophen, Chlorpheniramine, and Phenylephrine Effervescent Tablets Acetaminophen, Chlorpheniramine, and Phenylephrine Tablets Other brands: Alka-Seltzer Plus Cold , Norel AD , GNP Cold Relief Plus , Allergy Multi-Symptom , ... +12 more Related treatment guides Sinus Symptoms Cold Symptoms} Drug Status Rx OTC Availability Rx and/or OTC N Pregnancy Category Not classified N/A CSA Schedule Not a controlled drug WADA Class Anti-Doping Classification Acetaminophen / chlorpheniramine / phenylephrine Rating 8 User Reviews 6.8 /10 8 User Reviews 6.8 Rate it! Drug Class Upper respiratory combinations Related Drugs Sinus Symptoms Nasonex , mometasone nasal , Alka-Seltzer Plus Cold , Deconex , Norel AD , Advil Cold and Sinus , Crantex , naproxen / pseudoephedrine , More... Cold Symptoms diphenhydramine , Benadryl , Promethazine DM , chlorpheniramine , echinacea , Tussionex Pennkinetic , Banophen , Benadryl Allergy , Chlor-Trimeton , Guaifenex , Triaminic , Promethazine with Dextromethorphan , More...} } superb


out of practice SM Allergy Multi-Symptom a number of